Fig. 2
![Fig. 2](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12879-021-06226-0/MediaObjects/12879_2021_6226_Fig2_HTML.png)
Longitudinal analysis of ALT of chronic HBV patients with TDF treatment vs. without treatment. (A) Distribution of ALT levels at each time point; (B) Stratifications of ALT levels at each time point. * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001, **** p-value < 0.0001. ALT, Alanine aminotransferase; TDF, Tenofovir disoproxil fumarate